Takeda clears key hurdle as investors back $59 billion Shire deal
2018-12-5 05:48 pm
Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt.
Read The Rest at
Russia's Gazprom Neft sticking with plan to...
Unilever's Polman calls for trust in farewell...
You May Also Like
A 72-year-old Dallas man fatally shot a...
Chase Elliott roars back from 37th to 1st in...
Hurdle fired, Reds beat Pirates 3-1 in season...
Celebrate 64 Years of Arthur Miller's A View...
Rutgers could turn back to Greg Schiano after...
Saudi Arabia to invest $100 billion in India
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version